Stocks
Sarepta Therapeutics (SRPT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -13.9 | -27.4 | -20.7 | -18.9 | -19.7 | 49.8 | ||
| Changes by years, y/y, % | -26% | +96% | -24% | -9% | +4% | +0.8% | |||
Sarepta Therapeutics. EV/EBITDA
Sarepta Therapeutics. EV/EBITDA, changes, %
Sarepta Therapeutics (SRPT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -33.4 | -51.7 | -3 966 | 134.7 | 79.0 | 49.8 | |
| Changes by years, y/y, % | +77% | +122% | +17 180% | -661% | -336% | |||
| Changes by quarters, q/q, % | +39% | +55% | +7 568% | -103% | -41% | |||
